Anavex Life Sciences Corp (AVXL)

[RedShoulder]

'Anavex Alzheimer's And Parkinson's Drug Underappreciated By Investors' ... thanks for the summary bas; I thought this point was laid out well. I'll go with Dr Jin looking at the data over any contradictory poster which doesn't have Dr Jin's skills, and not having the data that he has at his disposal and purview.

"The September press release declaring again the AD trial a "success" was published six months after the hiring of Dr. Jin, so if there is any question about the veracity of the "successful" Phase 2b/3 trial, it is on Dr. Jin's name. And it is up to you, the individual investor, to decide whether you trust Dr. Jin or if you trust certain writers who claimed that Anavex could not even subtract numbers accurately.

My hunch is that Dr. Jin will not risk his reputation by writing a press release that does not meet strict statistical standards. So when Anavex says that a p<.025 on both the ADAS-Cog and the CDR-SB combined with statistically significant findings in two important biomarkers spells a successful trial, I expect it to be true."